September 10, 2020
September 10, 2020
AstraZeneca aims to transform cancer treatment and advance clinical practice with data presented at ESMO 2020
AstraZeneca will present new developments in pursuit of its ambition to eliminate cancer as a cause of death at the European Society for Medical... Read More
September 10, 2020
Natera Launches Proposed Follow-On Offering
Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced the launch of a proposed follow-on public offering of $250,000,000 of... Read More
September 10, 2020
Lilly Oncology to Showcase New Data from Robust Cancer Research Pipeline at ESMO Virtual Congress 2020
Data from 20 studies across Eli Lilly and Company’s (NYSE: LLY) oncology product portfolio will be presented at the European Society for Medical Oncology... Read More
September 10, 2020
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx)... Read More
September 3, 2020
Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research & Development
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced the appointment of... Read More
September 3, 2020
U.S. Food and Drug Administration Approves Onureg® (azacitidine tablets), a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia
Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Onureg® (azacitidine 300 mg tablets, CC-486) for... Read More
September 3, 2020
Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System*
In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today,... Read More
August 17, 2020
Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.T
Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui... Read More
August 17, 2020
OneOncology and Foundation Medicine Unveil First-of-its-Kind Partnership to Advance Personalized Medicine at Community Oncology Practices
Foundation Medicine, Inc. and OneOncology today announced a new joint initiative that is intended to better enable OneOncology partner practice physicians to unlock the... Read More
August 8, 2020
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
–Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and robust... Read More
August 7, 2020
Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers
Guardant Health, Inc. (Nasdaq: GH) announces that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx for tumor mutation profiling, also known... Read More
August 7, 2020
Ancestry® Launches AncestryHealth® Powered by Next Generation Sequencing (NGS)
Ancestry®, the global leader in family history and consumer genomics, today announced the launch of AncestryHealth® powered by Next Generation Sequencing (NGS), signifying a... Read More
July 23, 2020
Genetic testing for heart diseases may help patients and families identify risks
Genetic testing and counseling for inherited cardiovascular diseases may help patients and their families make well-informed decisions about managing their heart health, according to... Read More
July 23, 2020
Konica Minolta Precision Medicine (KMPM) Launches Care for COVID Program
Ambry Genetics Corporation (Ambry), a leading clinical genetic testing laboratory, announced the launch of its CARE for COVID Program to provide employers with the... Read More
July 23, 2020
Novartis announces Phase III study of Jakavi® in chronic graft-versus-host disease met primary and key secondary endpoints
Novartis today announced that the Phase III REACH3 study evaluating Jakavi® (ruxolitinib) in patients with steroid-refractory or steroid-dependent chronic graft-versus-host disease (GvHD) met its... Read More
July 23, 2020
European Medicines Agency Validates Bristol Myers Squibb’s Application for CAR T Cell Therapy Lisocabtagene Maraleucel (liso-cel)
Bristol Myers Squibb (NYSE: BMY) have announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Application (MAA) for lisocabtagene maraleucel (liso-cel),... Read More
July 23, 2020
Thermo Fisher Scientific’s Response to COVID-19 Continues to Expand to Support Development and Production of Therapeutics and Vaccines
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services... Read More
July 17, 2020
Multiple Myeloma Research Foundation (MMRF) Launches CureCloud to Democratize Healthcare for Cancer Patients
The Multiple Myeloma Research Foundation (MMRF) is working to democratize healthcare for cancer patients today with the launch of CureCloud®, a first-of-its-kind, direct-to-patient research... Read More
July 17, 2020
Huntsman Cancer Institute Announces Next Major Expansion
A $4.5 million gift from the Huntsman family will fund an expansion of a unique program at Huntsman Cancer Institute (HCI) at the University... Read More
July 17, 2020
CHI Franciscan And Virginia Mason Sign Memorandum Of Understanding To Explore Combining And Forming New Integrated Health System
Washington-based health systems, CHI Franciscan and Virginia Mason, along with CommonSpirit Health, the parent company of CHI Franciscan, announced today they have signed a... Read More
July 16, 2020
Adaptive Biotechnologies Announces Pricing of Public Offering of Common Stock
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products... Read More
July 16, 2020
Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia
Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice,... Read More
July 16, 2020
Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global... Read More
July 16, 2020
Israel Ministry of Health Expands Testing Coverage for Non-Small Cell Lung Cancer Patients
Starting this month, comprehensive molecular profiling is now covered for patients with non-small cell lung cancer (NSCLC) in Israel, as outlined in a letter... Read More
Tweets
Just over one week remains to register for the PMLS Precision Diagnostics Virtual Summit. Hear from leaders from ac… https://t.co/KwkMCdLOA2, - New post: Bristol Myers Squibb Research at ESMO Virtual Congress 2020 Highlights Significant Progress in Cancers https://t.co/0DxxAqKtfb,
- New post: AstraZeneca aims to transform cancer treatment and advance clinical practice with data presented at ESMO https://t.co/S7dHpEmDay,